ID   DPM3_HUMAN              Reviewed;          92 AA.
AC   Q9P2X0; Q5SR62; Q5SR63; Q9BXN4; Q9BXN5;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   12-APR-2017, entry version 133.
DE   RecName: Full=Dolichol-phosphate mannosyltransferase subunit 3;
DE   AltName: Full=Dolichol-phosphate mannose synthase subunit 3;
DE            Short=DPM synthase subunit 3;
DE   AltName: Full=Dolichyl-phosphate beta-D-mannosyltransferase subunit 3;
DE   AltName: Full=Mannose-P-dolichol synthase subunit 3;
DE            Short=MPD synthase subunit 3;
DE   AltName: Full=Prostin-1;
GN   Name=DPM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 1-13,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=10835346; DOI=10.1093/emboj/19.11.2475;
RA   Maeda Y., Tanaka S., Hino J., Kangawa K., Kinoshita T.;
RT   "Human dolichol-phosphate-mannose synthase consists of three subunits,
RT   DPM1, DPM2 and DPM3.";
RL   EMBO J. 19:2475-2482(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11420690; DOI=10.1038/sj.onc.1204379;
RA   Manos E.J., Kim M.L., Kassis J., Chang P.Y., Wells A., Jones D.A.;
RT   "Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel
RT   phospholipase C-gamma regulated gene negatively associated with
RT   prostate tumor invasion.";
RL   Oncogene 20:2781-2790(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANT CDG1O SER-85, AND CHARACTERIZATION OF VARIANT CDG1O SER-85.
RX   PubMed=19576565; DOI=10.1016/j.ajhg.2009.06.006;
RA   Lefeber D.J., Schonberger J., Morava E., Guillard M., Huyben K.M.,
RA   Verrijp K., Grafakou O., Evangeliou A., Preijers F.W., Manta P.,
RA   Yildiz J., Grunewald S., Spilioti M., van den Elzen C., Klein D.,
RA   Hess D., Ashida H., Hofsteenge J., Maeda Y., van den Heuvel L.,
RA   Lammens M., Lehle L., Wevers R.A.;
RT   "Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital
RT   disorders of glycosylation with the dystroglycanopathies.";
RL   Am. J. Hum. Genet. 85:76-86(2009).
CC   -!- FUNCTION: Stabilizer subunit of the dolichol-phosphate mannose
CC       (DPM) synthase complex; tethers catalytic subunit DPM1 to the ER.
CC       {ECO:0000269|PubMed:10835346}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the dolichol-phosphate mannose (DPM)
CC       synthase complex composed of DPM1, DPM2 and DPM3; in the complex
CC       associated with DPM1 via its C-terminal domain and with DPM2 via
CC       its N-terminal portion. {ECO:0000269|PubMed:10835346}.
CC   -!- INTERACTION:
CC       O60762:DPM1; NbExp=4; IntAct=EBI-9087337, EBI-719526;
CC       Q9Z325:Dpm2 (xeno); NbExp=2; IntAct=EBI-9087337, EBI-9097185;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Short;
CC         IsoId=Q9P2X0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Long;
CC         IsoId=Q9P2X0-2; Sequence=VSP_001308;
CC   -!- DISEASE: Congenital disorder of glycosylation 1O (CDG1O)
CC       [MIM:612937]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. CDG1O patients have increased serum creatine
CC       kinase, dystrophic changes on muscle biopsy, and reduced O-
CC       mannosylation of alpha-dystroglycan.
CC       {ECO:0000269|PubMed:19576565}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DPM3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028128; BAA96291.1; -; mRNA.
DR   EMBL; AF312922; AAK28487.1; -; mRNA.
DR   EMBL; AF312923; AAK28486.1; -; mRNA.
DR   EMBL; AL691442; CAI15325.1; -; Genomic_DNA.
DR   EMBL; AL691442; CAI15326.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53126.1; -; Genomic_DNA.
DR   EMBL; BC104202; AAI04203.1; -; mRNA.
DR   EMBL; BC104203; AAI04204.1; -; mRNA.
DR   CCDS; CCDS1094.1; -. [Q9P2X0-2]
DR   CCDS; CCDS1095.1; -. [Q9P2X0-1]
DR   RefSeq; NP_061846.2; NM_018973.3. [Q9P2X0-2]
DR   RefSeq; NP_714963.1; NM_153741.1. [Q9P2X0-1]
DR   RefSeq; XP_016856987.1; XM_017001498.1. [Q9P2X0-1]
DR   UniGene; Hs.110477; -.
DR   ProteinModelPortal; Q9P2X0; -.
DR   BioGrid; 119935; 8.
DR   IntAct; Q9P2X0; 11.
DR   STRING; 9606.ENSP00000357384; -.
DR   iPTMnet; Q9P2X0; -.
DR   PhosphoSitePlus; Q9P2X0; -.
DR   SwissPalm; Q9P2X0; -.
DR   BioMuta; DPM3; -.
DR   DMDM; 125987822; -.
DR   EPD; Q9P2X0; -.
DR   MaxQB; Q9P2X0; -.
DR   PaxDb; Q9P2X0; -.
DR   PeptideAtlas; Q9P2X0; -.
DR   PRIDE; Q9P2X0; -.
DR   TopDownProteomics; Q9P2X0-1; -. [Q9P2X0-1]
DR   TopDownProteomics; Q9P2X0-2; -. [Q9P2X0-2]
DR   DNASU; 54344; -.
DR   Ensembl; ENST00000341298; ENSP00000344338; ENSG00000179085. [Q9P2X0-1]
DR   Ensembl; ENST00000368399; ENSP00000357384; ENSG00000179085. [Q9P2X0-2]
DR   Ensembl; ENST00000368400; ENSP00000357385; ENSG00000179085. [Q9P2X0-1]
DR   GeneID; 54344; -.
DR   KEGG; hsa:54344; -.
DR   UCSC; uc001fhm.3; human. [Q9P2X0-1]
DR   CTD; 54344; -.
DR   DisGeNET; 54344; -.
DR   GeneCards; DPM3; -.
DR   GeneReviews; DPM3; -.
DR   HGNC; HGNC:3007; DPM3.
DR   HPA; HPA014667; -.
DR   MalaCards; DPM3; -.
DR   MIM; 605951; gene.
DR   MIM; 612937; phenotype.
DR   neXtProt; NX_Q9P2X0; -.
DR   OpenTargets; ENSG00000179085; -.
DR   Orphanet; 263494; DPM3-CDG.
DR   PharmGKB; PA27465; -.
DR   eggNOG; KOG4841; Eukaryota.
DR   eggNOG; ENOG41121C3; LUCA.
DR   GeneTree; ENSGT00390000008892; -.
DR   HOGENOM; HOG000038272; -.
DR   HOVERGEN; HBG018968; -.
DR   InParanoid; Q9P2X0; -.
DR   KO; K09659; -.
DR   OMA; YREVAWP; -.
DR   OrthoDB; EOG091G140M; -.
DR   PhylomeDB; Q9P2X0; -.
DR   TreeFam; TF300274; -.
DR   Reactome; R-HSA-162699; Synthesis of dolichyl-phosphate mannose.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; DPM3; -.
DR   GenomeRNAi; 54344; -.
DR   PRO; PR:Q9P2X0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000179085; -.
DR   CleanEx; HS_DPM3; -.
DR   ExpressionAtlas; Q9P2X0; baseline and differential.
DR   Genevisible; Q9P2X0; HS.
DR   GO; GO:0033185; C:dolichol-phosphate-mannose synthase complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:HGNC.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:HGNC.
DR   GO; GO:0031501; C:mannosyltransferase complex; TAS:HGNC.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc.
DR   GO; GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0018406; P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan; TAS:HGNC.
DR   GO; GO:0035268; P:protein mannosylation; TAS:HGNC.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome.
DR   GO; GO:0035269; P:protein O-linked mannosylation; TAS:HGNC.
DR   GO; GO:0031647; P:regulation of protein stability; IPI:UniProtKB.
DR   InterPro; IPR013174; DPM3.
DR   PANTHER; PTHR16433:SF1; PTHR16433:SF1; 1.
DR   Pfam; PF08285; DPM3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Congenital muscular dystrophy;
KW   Direct protein sequencing; Disease mutation; Dystroglycanopathy;
KW   Endoplasmic reticulum; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     92       Dolichol-phosphate mannosyltransferase
FT                                subunit 3.
FT                                /FTId=PRO_0000195000.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TRANSMEM     37     57       Helical. {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MLSVGGLRLSLVRFSFLLLRGALLPSLAVTM (in
FT                                isoform 2). {ECO:0000303|PubMed:11420690,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001308.
FT   VARIANT      85     85       L -> S (in CDG1O; affects interaction
FT                                with DPM1; dbSNP:rs121908155).
FT                                {ECO:0000269|PubMed:19576565}.
FT                                /FTId=VAR_062518.
FT   CONFLICT     90     90       L -> V (in Ref. 1; BAA96291).
FT                                {ECO:0000305}.
SQ   SEQUENCE   92 AA;  10094 MW;  C350A6896842A877 CRC64;
     MTKLAQWLWG LAILGSTWVA LTTGALGLEL PLSCQEVLWP LPAYLLVSAG CYALGTVGYR
     VATFHDCEDA ARELQSQIQE ARADLARRGL RF
//
